Submit Deal

DAIICHI SANKYO COMPANY LIMITED

Deals Overview

Total Deals5

Valued Deals2

Total Value£ 5.41 B

Avg. Deal Size£ 2.70 B

Market Context

Senior Management

George Nakayama
Chairman and CEO
Joji Nakayama
CEO
Sunao Manabe
Representative Director, President and CEO

Sort

16 Apr 2015|India|Pharmaceuticals

Target: SUN PHARMACEUTICAL INDUSTRIES LTD

Bidder: DAIICHI SANKYO COMPANY LIMITED

1 Service Providers

1 Bidder

2 Dealmakers

2 Bidder

n/a

Value

28 Mar 2019|Japan|Pharmaceuticals

Target: DAIICHI SANKYO (TRASTUZUMAB DERUXTECAN)

Bidder: ASTRAZENECA PLC

3 Service Providers

2 Bidder | 1 Vendor

11 Dealmakers

5 Bidder | 6 Vendor

£ 5.26 B

Value

01 Apr 2020|France|Pharmaceuticals

Target: DAIICHI SANKYO ALTKIRCH SARL

Bidder: AMERICAN REGENT INC

2 Service Providers

1 Bidder | 1 Vendor

3 Dealmakers

2 Bidder | 1 Vendor

n/a

Value

18 Jan 2022|Japan|Pharmaceuticals

Target: DAIICHI SANKYO (EIGHT BRANDED COMMERCIAL PRODUCTS)

Bidder: COSETTE PHARMACEUTICALS

5 Service Providers

3 Bidder | 2 Vendor

5 Dealmakers

4 Bidder | 1 Vendor

n/a

Value

15 May 2023|Japan|Pharmaceuticals

Target: DAIICHI SANKYO ESPHA CO

Bidder: QOL HOLDINGS

1 Service Providers

1 Bidder

£ 147 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Senior Management

George Nakayama
Chairman and CEO
Joji Nakayama
CEO
Sunao Manabe
Representative Director, President and CEO